Home
Product

Porphyromonas gingivalis

While typically known as a periodontal pathogen, attenuated or engineered versions of Porphyromonas gingivalis are being studied for niche-specific applications. Researchers aim to engineer its unique protein secretion systems to deliver anti-inflammatory signals within the subgingival biofilm. Its application prospect is highly specialized toward treating chronic periodontitis and related systemic inflammatory conditions.

Genetically Modified Probiotics

CAT#	Product Name	Product Overview	Add to basket
LBGF-0126-GF73	Porphyromonas gingivalisΔPPAD	This mutant strain of a primary periodontal pathogen is engineered to lack a specific enzyme linked to rheumatoid arthritis. It is a critical tool for studying how oral health influences systemic autoimmune diseases.	Inquiry
LBGF-0126-GF74	Porphyromonas gingivalis Δltp1	This is a signaling-deficient mutant of P. gingivalis. It is designed to study how this bacterium communicates with other species in the oral biofilm, particularly Streptococcus gordonii.	Inquiry
LBGF-0126-GF75	Porphyromonas gingivalis Δphp1	This mutant strain lacks a key protein phosphatase, rendering it less capable of adapting to the stressful environment of the human mouth.	Inquiry
LBGF-0126-GF94	Porphyromonas gingivalis-lux	This is a bioluminescent version of a primary gum disease pathogen. It generates its own light through a chemical reaction, allowing researchers to monitor its presence in deep "pockets" of the gums or inside living tissues without using a microscope.	Inquiry
LBGF-0126-GF97	Porphyromonas gingivalis-GFP	This is a green-fluorescent version of the P. gingivalis pathogen. It is the primary tool used to study how this bacterium invades human heart cells or "hitchhikes" inside immune cells to travel through the body.	Inquiry

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.